Key Takeaways for Arizona Dentists
- Arizona dental practices generating $1.5 million+ in annual revenue are in high demand from DSOs, with multiple affiliations recorded in 2026 and 69% of DSOs planning increased acquisition activity.
- DSO deals are rarely all-cash. Typical structures include cash, up to 40% equity rollover, and earnouts, which means you need to review non-compete terms and post-sale employment commitments carefully.
- A diligence-grade, CPA-led EBITDA valuation can be essential to defend add-backs and reduce the risk of price re-trading during buyer quality-of-earnings reviews.
- Running a structured, competitive bid process among vetted buyers can improve total transaction value by an average of 30% compared to selling to a single buyer.
- McLerran & Associates helps Arizona practice owners navigate DSO transitions with an 85–90% transaction rate and nearly $2 billion in closed volume. You can schedule a free, confidential discovery call to explore your options.
Who This Arizona DSO Guide Is For
This guide speaks to solo general dentists, specialists, and small-group owners in Arizona with practices generating roughly $1.5 million or more in annual revenue. Several terms appear throughout and are worth defining upfront.
- EBITDA — Earnings Before Interest, Taxes, Depreciation, and Amortization. DSOs use this profitability metric to value practices.
- Add-backs — Discretionary or non-recurring expenses added back to net income to arrive at true EBITDA.
- LOI — Letter of Intent. This non-binding agreement sets headline price and deal structure before formal diligence begins.
- Earnout — A portion of the purchase price paid after closing, contingent on hitting agreed performance targets.
- Equity rollover — A share of the deal paid as ownership in the DSO parent rather than cash.
- Recapitalization — A future event in which the DSO’s private equity sponsor sells or refinances the platform, creating a second liquidity event for equity holders.
Arizona follows a corporate-practice-of-dentistry doctrine, so a non-dentist entity cannot directly employ dentists or own a dental practice outright. DSOs operating in Arizona typically use a Management Services Agreement (MSA) structure, where a dentist-owned professional entity retains clinical control and the DSO provides administrative, operational, and business support services. This structure shapes how your ownership interest transfers and how your post-sale employment agreement reads.
Step 1: Confirm Readiness and Gather Core Financials
Readiness is both personal and financial. On the personal side, most DSO deals require a post-close employment commitment, and a minimum 5-year post-close working agreement is common. Owners who do not want that level of commitment may find the DSO path misaligned with their timeline.
On the financial side, gather at least 3 years of tax returns, profit-and-loss statements, and practice management software reports covering production, collections, and hygiene metrics. DSOs in 2026 are placing greater scrutiny on financials, operations, and practice performance projections, and incomplete documentation can stall or kill a deal. You trade speed for leverage at this stage. Moving quickly with incomplete records limits your negotiating power, while taking time to clean up financials can meaningfully improve your valuation outcome.
Step 2: Get a Diligence-Grade, CPA-Led EBITDA Valuation
A valuation sets the foundation for every negotiation that follows. A back-of-the-napkin number set by the buyer often becomes the anchor that quietly determines what you walk away with, and a weak analysis can be re-traded during diligence. A diligence-grade valuation unpacks every add-back, applies the correct EBITDA normalization by replacing the owner’s compensation with a market-rate replacement-doctor salary, and produces a number that can hold up when a buyer’s quality-of-earnings team reviews it.
Practices where the owner performs 90% or more of production can face valuation reductions due to concentration risk, because DSO buyers cannot reliably underwrite production that leaves with the seller. You can often improve your multiple by identifying and addressing that risk before going to market, for example by adding an associate or shifting some production. Actual valuation outcomes can depend on practice size, geography, payer mix, hygiene contribution, provider depth, collections quality, specialty mix, equipment needs, DSO fit, buyer competition, financing markets, and deal structure.
Step 3: Translate Valuation Into Arizona-Specific Deal Terms
Once you have a defensible EBITDA valuation in hand, the next step is to see how that number converts into actual dollars in your pocket. DSO deals in Arizona, as elsewhere, are almost never all-cash. Typical structures include a mix of cash, equity up to 40%, and earnout, with equity held at the joint-venture or holding-company level. When up to 40% of a deal is paid in equity rather than cash, you effectively buy stock in the DSO, so you evaluate that piece like an investment, not just a bonus.
Arizona’s sprawling Phoenix metro creates a specific non-compete consideration. Arizona enforces dental non-competes under a common law reasonableness test, and a 10-mile radius in the Phoenix metro can meaningfully restrict employment options. A 10-mile radius can cover much of the metro area, which can limit where you can work if you leave the DSO. Because of that reach, the geographic scope and duration of your non-compete become material economic terms. You also want the non-compete placed in the asset purchase agreement, not solely in the employment agreement, so the restriction ties to the sale terms rather than only to your job description.
Earnout and rollover terms are fixed in the letter of intent, where DSO teams have significant negotiating experience, and buyers often treat attempts to change these terms after LOI signing as bad-faith renegotiation. You usually need to negotiate structure details before signing the LOI, not after.
Step 4: Run a Competitive, Auction-Like Process With Vetted Buyers
Talking to a single DSO usually produces a single offer with no competitive tension. McLerran & Associates runs a structured, auction-like bid process over roughly 45 to 60 days that often generates around 10 offers from a vetted pool of well-qualified DSO and private equity buyers. DSOs known for poor post-close environments are blacklisted and do not reach the table.
Demand remains steep for premier, Class A practices, and valuations sit near all-time highs. This environment makes the quality of your marketing materials and EBITDA narrative especially important. A competitive process typically narrows from initial offers to in-person meetings with the top 1 to 3 finalists. That sequence gives you real market data instead of a single buyer’s self-interested number. A competitive sales process can improve total transaction value by an average of 30% compared to selling on your own.
Step 5: Turn Offers Into an LOI, Defend Earnings, and Close
Once you have multiple offers in hand from that competitive process, the next step is to negotiate the best offer into a binding letter of intent. The LOI locks in valuation and deal structure. Every term negotiated here, including cash at close percentage, equity class, earnout measurement basis, non-compete scope, and post-sale employment duration and compensation, shapes your actual outcome. After the LOI, the buyer’s quality-of-earnings team reviews every add-back in your EBITDA analysis. Without an advisor defending that analysis, buyers can use diligence to push the price downward.
Sellers can sometimes negotiate more balanced earnout terms by requiring linear pro-rata payouts instead of cliffs, locking expense allocations in writing to limit DSO cost shifting, carving out buyer-imposed operational changes, and including acceleration clauses if the DSO sells the practice during the earnout period. The closing process on a DSO deal typically runs 3 to 6 months from LOI to close, and deals can fall apart at several points without an experienced advocate managing the process.
Talk to McLerran & Associates about defending your EBITDA through diligence. Brian Carroll leads the Phoenix office and covers the Mountain West. Call (512) 900-7989 or email info@dentaltransitions.com.
Deal Structure Examples for Arizona Sellers
The buyer-comparison matrix below illustrates how deal structure can vary across buyer types for a hypothetical Phoenix-area general dentistry practice with $2 million in collections and approximately $600,000 in adjusted EBITDA. All figures are illustrative and based on ranges reported in McLerran transaction data and published industry sources. Notice how PE-backed platforms tend to offer the highest multiples but also require the largest equity rollover and lowest cash-at-close percentage, so you trade immediate liquidity for potential upside at a future recapitalization event. Consult your tax and legal advisors regarding your specific situation.
| Structure Element | Solo Add-On DSO | Regional Platform DSO | PE-Backed Platform |
|---|---|---|---|
| EBITDA Multiple Range | 5.0x–6.5x | 7.0x–9.0x | 9.0x–11.0x |
| Cash at Close (% of total) | 75–85% | 70–80% | 65–75% |
| Rollover Equity (% of total) | 10–20% | 15–25% | 20–30% |
The cash-flow forecast table below models illustrative after-tax proceeds for the same hypothetical practice across time horizons, assuming one recapitalization event in years 5 to 7. Use this table to compare the total economic outcome of keeping your practice versus selling to a DSO with different equity structures. Equity-weighted DSO deals can sometimes outperform cash-heavy structures only if you hold through a successful recapitalization event and the platform performs well. These figures are illustrative only and are not a guarantee of any specific outcome.
| Scenario | 3-Year Horizon | 5-Year Horizon | 7–10-Year Horizon |
|---|---|---|---|
| Keep Practice (distributions only) | ~$1.2M pre-tax | ~$2.0M pre-tax | ~$2.8M–$4.0M pre-tax |
| DSO Add-On (cash-heavy structure) | ~$2.5M–$3.0M at close + salary | ~$3.0M–$3.5M total (earnout resolved) | ~$3.5M–$4.5M (equity at recap) |
| DSO Platform (equity-weighted) | ~$2.0M–$2.5M at close + salary | ~$3.5M–$4.5M (earnout + equity) | ~$5.0M–$7.0M+ (equity at recap) |
Much of a DSO deal’s proceeds may qualify for long-term capital gains tax treatment rather than ordinary income rates, which can materially affect after-tax outcomes. A CPA familiar with dental transactions should model your specific situation before you sign an LOI.
Common Challenges and How to Prevent Them
Several issues can surface between initial offer and closing, and recognizing them early can reduce the risk of a deal collapsing or being re-traded.
- Valuation gaps. A buyer’s quality-of-earnings team challenges add-backs the seller’s advisor did not fully document. Prevention: build a diligence-grade EBITDA analysis before going to market, with every add-back supported by documentation.
- Incomplete financials. Missing tax returns, inconsistent practice management reports, or unreconciled collections data slow diligence and signal risk to buyers. Prevention: reconcile 3 years of financials before the process begins.
- Owner-dependence concentration risk. The concentration risk discussed in Step 2 can surface during diligence as a valuation gap. Prevention: add an associate or document a credible transition plan before marketing.
- Confidentiality breaches. Staff or patients learning of a potential sale before closing can destabilize the practice and reduce its value. Prevention: use a structured, confidential process with non-disclosure agreements executed before any buyer receives practice information.
- Buyer-fit misalignment. The highest bidder may not be the right partner for your staff, patients, or post-sale clinical environment. Prevention: vet buyers on culture, financial strength, and track record, not just headline price.
How to Measure a Successful DSO Transition
A successful DSO transition can be evaluated against several objective indicators that reflect both economics and practice health.
- Valuation quality: the agreed EBITDA holds through diligence without re-trading.
- Depth of competition: the process generates genuine competition, often around 10 offers in a well-run auction.
- Timeline adherence: the process closes within the projected 45-to-60-day bid window and 3-to-6-month closing timeline.
- Diligence outcomes: add-backs are defended and the agreed price is preserved.
- Staff and patient retention: key team members remain through and after the transition.
- Owner goal alignment: the final structure, including cash, equity, earnout, and employment terms, matches what the owner defined as success at the outset.
Frequently Asked Questions
What is the “two-year rule” in Arizona DSO deals, and does it apply to my situation?
The “two-year rule” is an informal reference to post-sale employment commitments, not a statutory Arizona requirement. In practice, DSO employment agreements in Arizona commonly run 3 to 5 years, and some buyers now require a minimum 5-year term as a condition of closing. The specific duration can depend on your practice’s provider depth, your role in production, and the buyer’s integration model. Shorter commitments may be negotiable if you have already reduced your chair time and have associates in place, but this remains a deal-by-deal determination that you should negotiate before signing the LOI.
I received an unsolicited DSO offer. Should I respond directly?
Responding directly to a single unsolicited offer usually puts you at a significant disadvantage. The DSO’s team negotiates acquisitions regularly, and you are likely selling once. Engaging without competitive tension often means accepting whatever structure and price that buyer proposes, with no market data to support a counter. A more productive approach is to treat the unsolicited offer as a signal that your practice is marketable, then run a structured process that surfaces multiple offers at the same time. That competition can be one of the main factors that moves price and improves terms.
How are non-compete clauses typically structured in Arizona DSO deals, and are they enforceable?
As discussed in Step 3, Arizona enforces non-competes in the sale-of-business context under a reasonableness standard that weighs geographic scope, duration, and the legitimate business interest being protected. Beyond the basics covered there, Arizona courts apply the blue-pencil doctrine, which means they may modify an overbroad restriction rather than void it entirely. The non-compete should be placed in the asset purchase agreement itself, not solely in the employment agreement, so it ties directly to the sale terms. Work with a dental-specific attorney to evaluate the specific language proposed in your transaction.
When is the right time to sell my Arizona dental practice to a DSO?
Demand for premier Arizona practices remains strong, and valuations are near historically high levels as of mid-2026. Timing still remains practice-specific. Practices with owner-dependence concentration, incomplete financials, or deferred equipment needs may benefit from a preparation period before going to market. Adding an associate, cleaning up reporting, or addressing facility issues can sometimes improve your multiple. If you are not ready to sell today, a reputable advisor can update your valuation later rather than push you into a deal that does not align with your goals.
What happens to my rollover equity if the DSO underperforms?
Rollover equity is typically illiquid for 5 to 7 years until the platform recapitalizes or sells, and its realized value depends on the DSO’s future performance and exit timing. If the DSO underperforms, your equity stake can be worth significantly less than projected, or in extreme cases, very little. This risk is why vetting the DSO as an investment, including its profitability, revenue growth at existing offices, management team, and private equity backing, can be as important as negotiating the headline price. Protective terms such as tag-along rights, put options, anti-dilution provisions, and information rights can reduce but not fully remove this risk.
Conclusion: Next Steps for Arizona Practice Owners
Selling your dental practice to a DSO in Arizona is usually a once-in-a-lifetime transaction against sophisticated buyers who negotiate every week. A structured, sell-side auction process built on a diligence-grade EBITDA valuation, competitive tension across vetted buyers, and disciplined LOI negotiation can be one of the main factors that separates a good outcome from a great one. McLerran & Associates’ Phoenix office, led by Brian Carroll, has guided practice owners through this process with an approximately 85–90% transaction rate and a track record of roughly $2 billion in closed transaction volume.
Find out what your Arizona practice is worth in today’s DSO market. Call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com/contact-us.
